Words of wisdom. Re: Impact of risk factors on the performance of the nuclear matrix protein 22 point-of-care test for bladder cancer detection. Lotan Y, Shariat SF; NMP22 Study Group. BJU Int 2008;101:1362-7
Eur Urol
.
2009 Jul;56(1):217-8.
doi: 10.1016/j.eururo.2009.04.014.
Authors
Robert S Svatek
1
,
Colin P Dinney
Affiliation
1
MD Anderson Cancer Center, Urologic Oncology, 1515 Holcombe, Unit 1373, Houston, TX 77030, USA.
[email protected]
PMID:
19995517
DOI:
10.1016/j.eururo.2009.04.014
No abstract available
Publication types
Comment